1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Anthrax in 1 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
Anthrax: An acute infection caused by the spore-forming bacteria BACILLUS ANTHRACIS. It commonly affects hoofed animals such as sheep and goats. Infection in humans often involves the skin (cutaneous anthrax), the lungs (inhalation anthrax), or the gastrointestinal tract. Anthrax is not contagious and can be treated with antibiotics.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shin, S | 1 |
Kim, YB | 1 |
Hur, GH | 1 |
1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Anthrax
Article | Year |
---|---|
Involvement of phospholipase A2 activation in anthrax lethal toxin-induced cytotoxicity.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 4-Aminobenzoic Acid; Acetophenones; Aminobenzoates; A | 1999 |